38 results on '"Hopkins, Kirsten"'
Search Results
2. Radiotherapy resources in Africa: an International Atomic Energy Agency update and analysis of projected needs
3. Investigating the Effect of Reirradiation or Systemic Therapy in Patients With Glioblastoma After Tumor Progression: A Secondary Analysis of NRG Oncology/Radiation Therapy Oncology Group Trial 0525
4. Suppl Text and Figures from Phase II Study of Radiotherapy and Temsirolimus versus Radiochemotherapy with Temozolomide in Patients with Newly Diagnosed Glioblastoma without MGMT Promoter Hypermethylation (EORTC 26082)
5. Global Pattern of Nasopharyngeal Cancer: Correlation of Outcome With Access to Radiation Therapy
6. Prognostic factors for survival and ambulatory status at 8 weeks with metastatic spinal cord compression in the SCORAD randomised trial
7. EANO guideline for the diagnosis and treatment of anaplastic gliomas and glioblastoma
8. Response to Letter to the Editor of Radiotherapy and Oncology regarding the paper entitled “50 years of radiotherapy research: Evolution, trends and lessons for the future“ by Berger et al. (December 2021, volume 165)
9. A phase I trial of carboplatin administered by convection-enhanced delivery to patients with recurrent/progressive glioblastoma multiforme
10. Estimating the percentage of patients who might benefit from proton beam therapy instead of X-ray radiotherapy
11. 50 years of radiotherapy research: Evolution, trends and lessons for the future
12. Directions of Change in Rural Egypt
13. 13 Chemotherapy and other adjuvant therapies
14. 14 Biologically targeted radionuclide therapy
15. Effect of Single-Fraction vs Multifraction Radiotherapy on Ambulatory Status Among Patients With Spinal Canal Compression From Metastatic Cancer
16. Short delay in initiation of radiotherapy for patients with glioblastoma-effect of concurrent chemotherapy: a secondary analysis from the NRG Oncology/Radiation Therapy Oncology Group database
17. Rindopepimut with temozolomide for patients with newly diagnosed, EGFRvIII-expressing glioblastoma (ACT IV): a randomised, double-blind, international phase 3 trial
18. SCORAD III: Randomized noninferiority phase III trial of single-dose radiotherapy (RT) compared to multifraction RT in patients (pts) with metastatic spinal canal compression (SCC).
19. Randomized, Double-Blind, Placebo-Controlled, Multicenter Phase II Study of Onartuzumab Plus Bevacizumab Versus Placebo Plus Bevacizumab in Patients With Recurrent Glioblastoma: Efficacy, Safety, and Hepatocyte Growth Factor and O6-Methylguanine–DNA Methyltransferase Biomarker Analyses
20. Phase II study of radiotherapy and temsirolimus versus radiochemotherapy with temozolomide in patients with newly diagnosed glioblastoma without MGMT promoter hypermethylation (EORTC 26082)
21. Phase II Study of Radiotherapy and Temsirolimus versus Radiochemotherapy with Temozolomide in Patients with Newly Diagnosed Glioblastoma without MGMT Promoter Hypermethylation (EORTC 26082)
22. Multi-Center Randomized Phase II Study Comparing Cediranib plus Gefitinib with Cediranib plus Placebo in Subjects with Recurrent/Progressive Glioblastoma
23. The International Atomic Energy Agency global initiatives on nasopharyngeal cancer treatment
24. RTRB-03SHORT DELAY IN INITIATION OF RADIOTHERAPY WITH CONCURRENT CHEMOTHERAPY FOR GLIOBLASTOMA: A SECONDARY ANALYSIS OF NRG ONCOLOGY/RTOG 0525 AND 0825
25. ATCT-29INVESTIGATING THE EFFECT OF REIRRADIATION OR SYSTEMIC THERAPY IN PATIENTS WITH GBM AFTER TUMOR PROGRESSION: A SECONDARY ANALYSIS OF THE NRG ONCOLOGY/RTOG 0525
26. Onartuzumab plus bevacizumab versus placebo plus bevacizumab in recurrent glioblastoma (GBM): HGF and MGMT biomarker data.
27. EGFR and EGFRvIII analysis in glioblastoma as therapeutic biomarkers
28. A novel implantable catheter system with transcutaneous port for intermittent convection-enhanced delivery of carboplatin for recurrent glioblastoma
29. Isocitrate dehydrogenase mutation analysis in gliomas as a diagnostic and prognostic biomarker
30. A novel implantable catheter system with transcutaneous port for intermittent convection-enhanced delivery of carboplatin for recurrent glioblastoma.
31. Temozolomide Versus Procarbazine, Lomustine, and Vincristine in Recurrent High-Grade Glioma
32. Extended Survival in Women With Brain Metastases From HER2 Overexpressing Breast Cancer
33. EGFR and EGFRvlll analysis in glioblastoma as therapeutic biomarkers.
34. Letters to the Editor
35. Pharmacokinetics and dose estimates following intrathecal administration of 131I-monoclonal antibodies for the treatment of central nervous system malignancies
36. P27 DEVELOPMENT OF AN IMPLANTABLE CATHETER AND BONE-ANCHORED PORT FOR INTERMITTENT CONVECTION-ENHANCED DELIVERY OF CARBOPLATIN FOR RECURRENT HIGH GRADE GLIOMA.
37. Direct Injection of 90Y MoAbs into Glioma Tumor Resection Cavities Leads to Limited Diffusion of the Radioimmunoconjugates into Normal Brain Parenchyma: A Model to Estimate Absorbed Radiation Dose
38. Randomized, Double-Blind, Placebo-Controlled, Multicenter Phase II Study of Onartuzumab Plus Bevacizumab Versus Placebo Plus Bevacizumab in Patients With Recurrent Glioblastoma: Efficacy, Safety, and Hepatocyte Growth Factor and O 6 -Methylguanine-DNA Methyltransferase Biomarker Analyses.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.